4//SEC Filing
Ginascol John F 4
Accession 0001415889-23-003053
CIK 0000001800other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:56 PM ET
Size
7.4 KB
Accession
0001415889-23-003053
Insider Transaction Report
Form 4
Ginascol John F
Executive Vice President
Transactions
- Award
Option (right to buy)
2023-02-17+56,275→ 56,275 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (56,275 underlying) - Award
Common shares without par value
2023-02-17+14,270→ 126,182 total
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,758 on February 17, 2024, 18,758 on February 17, 2025, and 18,759 on February 17, 2026.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001778075
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 6:56 PM ET
- Size
- 7.4 KB